- Home
- CRVO vs YMAT Comparison
CRVO vs YMAT Comparison
Compare CRVO & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- YMAT
- Stock Information
- Founded
- CRVO 2001
- YMAT 1970
- Country
- CRVO United States
- YMAT Taiwan
- Employees
- CRVO N/A
- YMAT N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- YMAT Recreational Games/Products/Toys
- Sector
- CRVO Health Care
- YMAT Consumer Discretionary
- Exchange
- CRVO Nasdaq
- YMAT Nasdaq
- Market Cap
- CRVO 67.4M
- YMAT 76.4M
- IPO Year
- CRVO N/A
- YMAT 2025
- Fundamental
- Price
- CRVO $10.51
- YMAT $1.24
- Analyst Decision
- CRVO Strong Buy
- YMAT
- Analyst Count
- CRVO 6
- YMAT 0
- Target Price
- CRVO $20.80
- YMAT N/A
- AVG Volume (30 Days)
- CRVO 119.1K
- YMAT 801.8K
- Earning Date
- CRVO 08-08-2025
- YMAT 01-01-0001
- Dividend Yield
- CRVO N/A
- YMAT N/A
- EPS Growth
- CRVO N/A
- YMAT N/A
- EPS
- CRVO N/A
- YMAT 0.07
- Revenue
- CRVO $7,776,968.00
- YMAT $17,563,985.00
- Revenue This Year
- CRVO N/A
- YMAT N/A
- Revenue Next Year
- CRVO N/A
- YMAT N/A
- P/E Ratio
- CRVO N/A
- YMAT $17.70
- Revenue Growth
- CRVO N/A
- YMAT N/A
- 52 Week Low
- CRVO $1.80
- YMAT $1.15
- 52 Week High
- CRVO $20.63
- YMAT $6.45
- Technical
- Relative Strength Index (RSI)
- CRVO 63.06
- YMAT N/A
- Support Level
- CRVO $9.61
- YMAT N/A
- Resistance Level
- CRVO $10.89
- YMAT N/A
- Average True Range (ATR)
- CRVO 0.67
- YMAT 0.00
- MACD
- CRVO 0.04
- YMAT 0.00
- Stochastic Oscillator
- CRVO 70.28
- YMAT 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.